@article{ART002867576},
author={Kyungsin Baek},
title={Experiential treatment of ankylosing spondylitis using Ortho-Cellular Nutrition Therapy (OCNT)},
journal={CELLMED},
issn={3022-6805},
year={2022},
volume={12},
number={3},
pages={14-14},
doi={10.5667/CellMed.2022.014}
TY - JOUR
AU - Kyungsin Baek
TI - Experiential treatment of ankylosing spondylitis using Ortho-Cellular Nutrition Therapy (OCNT)
JO - CELLMED
PY - 2022
VL - 12
IS - 3
PB - Cellmed Orthocellular Medicine and Pharmaceutical Association
SP - 14
EP - 14
SN - 3022-6805
AB - Currently, a 70-year-old woman started suffering from S.I joint pain from 1973 and had severe pain in the S.I joint, wrist, and elbow from 1975 to 1977, and was diagnosed with spinal tuberculosis at a general hospital. From 1978 to 1987, she suffered from chronic fatigue and insomnia, and since January 1, 1988, she was unable to get up while lying down, suffering from whole body joint, muscle pain, and fibromyalgia. In May 1989, she was also diagnosed with ankylosing spondylitis through genetic testing at the Catholic St. Mary's Hospital Rheumatology Department in Korea, and was treated with sulfasalazine, analgesic, and immunosuppressant, methotrexate, for 12 years until 1999, but none of the drugs eliminated the pain. She was hospitalized and discharged repeatedly, and continued to receive salt water poultice and exercise therapy at home, but was unable to move at all. In 2000, after biologic treatment with Remicade injection (Remsima®), she was able to walk and move, and after that, she was continuously prescribed biologics. From 2015 to 2019, Enbrel® (Etanercept) injection was prescribed once a week, but the symptoms such as severe pain (joint and muscle, fibromyalgia), scleroderma, Sjogren's syndrome (dryness of eyes, nose and mouth), difficulty swallowing, chronic fatigue, and stiff body appeared. Around January 2018, hepatic indicators were high and lymphocytes became enlarged. However, most serious injuries were highly improved after the OCNT combination therapy using active phytonutrients, anthocyanin-fucoidan nanocomplex. Therefore, for patients with such experiences, OCNT treatment is proposed as an alternative.
KW - Ortho-Cellular Nutrition Therapy;OCNT;ankylosing spondylitis;Cyaplex
DO - 10.5667/CellMed.2022.014
ER -
Kyungsin Baek. (2022). Experiential treatment of ankylosing spondylitis using Ortho-Cellular Nutrition Therapy (OCNT). CELLMED, 12(3), 14-14.
Kyungsin Baek. 2022, "Experiential treatment of ankylosing spondylitis using Ortho-Cellular Nutrition Therapy (OCNT)", CELLMED, vol.12, no.3 pp.14-14. Available from: doi:10.5667/CellMed.2022.014
Kyungsin Baek "Experiential treatment of ankylosing spondylitis using Ortho-Cellular Nutrition Therapy (OCNT)" CELLMED 12.3 pp.14-14 (2022) : 14.
Kyungsin Baek. Experiential treatment of ankylosing spondylitis using Ortho-Cellular Nutrition Therapy (OCNT). 2022; 12(3), 14-14. Available from: doi:10.5667/CellMed.2022.014
Kyungsin Baek. "Experiential treatment of ankylosing spondylitis using Ortho-Cellular Nutrition Therapy (OCNT)" CELLMED 12, no.3 (2022) : 14-14.doi: 10.5667/CellMed.2022.014
Kyungsin Baek. Experiential treatment of ankylosing spondylitis using Ortho-Cellular Nutrition Therapy (OCNT). CELLMED, 12(3), 14-14. doi: 10.5667/CellMed.2022.014
Kyungsin Baek. Experiential treatment of ankylosing spondylitis using Ortho-Cellular Nutrition Therapy (OCNT). CELLMED. 2022; 12(3) 14-14. doi: 10.5667/CellMed.2022.014
Kyungsin Baek. Experiential treatment of ankylosing spondylitis using Ortho-Cellular Nutrition Therapy (OCNT). 2022; 12(3), 14-14. Available from: doi:10.5667/CellMed.2022.014
Kyungsin Baek. "Experiential treatment of ankylosing spondylitis using Ortho-Cellular Nutrition Therapy (OCNT)" CELLMED 12, no.3 (2022) : 14-14.doi: 10.5667/CellMed.2022.014
